191 – 200 of 1292
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Germline heterozygous variants in genes associated with familial hemophagocytic lymphohistiocytosis as a cause of increased bleeding
(
- Contribution to journal › Article
-
Mark
Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial : effect of sociodemographic variables on participation, prostate cancer incidence and mortality
(
- Contribution to journal › Article
-
Mark
High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate
(
- Contribution to journal › Article
-
Mark
Platelet-derived microparticles regulates thrombin generation via phophatidylserine in abdominal sepsis
(
- Contribution to journal › Article
-
Mark
Acoustic Enrichment of Extracellular Vesicles from Biological Fluids
(
- Contribution to journal › Article
-
Mark
Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
(
- Contribution to journal › Article
-
Mark
ACouWash : A standalone instrument for the washing, separation and enrichment of cells.
2018) 22nd International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2018 In 22nd International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2018 1. p.279-281(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2017
-
Mark
Risk of spinal haematoma caused by epidural catheters af ter major upper gastrointestinal surgery: normal postoperative changes in coagulation, and the relationship between advanced and routine tests of coagulation
(
- Contribution to conference › Poster
-
Mark
High-Density Lipoprotein–Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1
(
- Contribution to journal › Article
-
Mark
Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study
(
- Contribution to journal › Article